Jsc Nextgen

This study tests a gene therapy called Neovasculgen in 180 women with painful bladder syndrome and Hunner's lesions. The goal is to reduce scarring from previous treatments and prevent the bladder from shrinking. Participants receive either the drug or a placebo, and doctors chec…

This Phase 3 trial is testing a drug called Neovasculgen, given as injections into the leg muscles, to see if it can help heal foot ulcers in people with diabetes. The study will include 144 adults with type 1 or type 2 diabetes who have a non-healing foot ulcer. Participants wil…

This study tests a gene therapy called Neovasculgen for people with painful bladder syndrome/interstitial cystitis, a condition causing pelvic pain and frequent urination. The treatment is injected into the bladder wall during a procedure. The goal is to reduce pain and prevent t…